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Abstract
Background: Schistosomiasis remains a major public health concern affecting billions of people around the world.
Currently, praziquantel is the only drug of choice for treatment of human schistosomiasis. The emergence of drug resistance
to praziquantel in schistosomes makes the development of novel drugs an urgent task. Thioredoxin glutathione reductase
(TGR) enzymes in Schistosoma mansoni and some other platyhelminths have been identified as alternative targets. The
present study was designed to confirm the existense and the potential value of TGR as a target for development of novel
antischistosomal agents in Schistosoma japonicum, a platyhelminth endemic in Asia.
Methods and Findings: After cloning the S. japonicum TGR (SjTGR) gene, the recombinant SjTGR selenoprotein was purified
and characterized in enzymatic assays as a multifunctional enzyme with thioredoxin reductase (TrxR), glutathione reductase
(GR) and glutaredoxin (Grx) activities. Immunological and bioinformatic analyses confirmed that instead of having separate
TrxR and GR proteins in mammalian, S. japonicum only encodes TGR, which performs the functions of both enzymes and
plays a critical role in maintaining the redox balance in this parasite. These results were in good agreement with previous
findings in Schistosoma mansoni and some other platyhelminths. Auranofin, a known inhibitor against TGR, caused fatal
toxicity in S. japonicum adult worms in vitro and reduced worm and egg burdens in S. japonicum infected mice.
Conclusions: Collectively, our study confirms that a multifunctional enzyme SjTGR selenoprotein, instead of separate TrxR
and GR enzymes, exists in S. japonicum. Furthermore, TGR may be a potential target for development of novel agents
against schistosomes. This assumption is strengthened by our demonstration that the SjTGR is an essential enzyme for
maintaining the thiol-disulfide redox homeostasis of S. japonicum.
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Introduction
Schistosomiasis is a major tropical disease endemic in Africa,
South America and Asia. It is estimated that approximately 600
million people are infected with the causative parasites in 76
countries around the world, and the disease results in about 20
million deaths annually [1–3]. In China, this disease caused by
Schistosoma Japonicum remains a major public health concern, with
more than 30 million people infected [4]. Currently, the control of
schistosomiasis mainly depends on drug-based chemotherapy [5].
Since praziquantel was developed in the 1980s, it has replaced
other drugs and became the first treatment of choice for
schistosomiasis [6,7]. However, praziquantel resistance or toler-
ance may arise after long-term, repeated large-scale chemotherapy
is implemented. Decreased sensitivity of Schistosoma mansoni to
praziquantel has been found in some endemic areas [8–12], and
several case reports of failure of repeated standard praziquantel
treatment to clear Schistosoma haematobium infections have also been
reported [13,14]. Although reduced sensitivity of S. japonicum to
praziquantel has not been proven to date, the efficacy of the drug
was reported to vary in different strains of this species [15].
Therefore, developing new antischistosomal agents to curb the
emergence of drug-resistant schisotomes should be given a high
priority.
Organisms are continuously attacked by endogenous and
exogenous reactive oxygen species (ROS). Affluent antioxidant
defense systems maintain the balance of pro-oxidants and anti-
oxidants in a stable redox state and protect the homeostasis of the
body. Two major systems exist to detoxify ROS in eukaryotes, the
thioredoxin (Trx) system and the glutathione (GSH) system [16].
The Trx system is composed of nicotinamide-adenine dinucleotide
phosphate (NADPH), Trx reductase (TrxR) and Trx. The GSH
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drives a tripeptide GSH-dependent system. Meanwhile, TrxR is
an NADPH-dependent selenoprotein containing the thiol-disulfide
redox active center [17], a GCUG active site motif located at the
carboxyl terminus where ‘‘U’’ represents selenocysteine. As an
important element in the active center of selenoproteins [18,19],
selenocysteine is exposed on the highly extended C-terminal surface
of TrxR. The Cys and SeCys residues in the reduced state have
strong pro-nuclear properties. Many electrophilic compounds can
selectively and irreversibly combine with the active center [20,21].
Both the Trx and GSH redox systems play an important role in the
anti-oxidative network, regulation of transcriptional factors, cell
growth and differentiation, synthesis of DNA, hormone action,
cytokine function and metabolism of selenoproteins. At present,
TrxR is considered a potential target for the development of novel
drugs against tumors and infectious pathogens [20,21].
In contrast to their mammalian hosts, thiol-disulfide redox
homeostasis in platyhelminths such as S. mansoni [22], larval Taenia
crassiceps (cysticerci) [23] Echinococcus granulosus [24] and Fasciola
hepatica [25], fully depend on thioredoxin glutathione redutase
(TGR) of linked thioredoxin-glutathione systems. It has been
demonstrated that there are no separate TrxR and GR enzymes in
S. mansoni and other platyhelminths. The functions are replaced by
the unique multi-functional enzyme_TGR. S. mansoni TGR
(SmTGR) with the activities of TrxR, GR and glutaredoxin
(Grx) has been confirmed by RNA interference as an essential
enzyme for S. mansoni survival [26]. Like all eukaryotic TrxR
isoforms, TGR is a selenoprotein with a GCUG active motif at the
carboxyl terminus [27]. Selenocysteine (U) is recoded by a
dedicated UGA codon in the selenoprotein mRNA by translation
machinery utilizing a specialized structural element, the seleno-
cysteine insertion sequence (SECIS). Following the silencing of
TGR expression or inhibition of its activity in S. mansoni, the
parasites die of oxidative damage from the host, suggesting that
SmTGR would be a promising and potential drug target [28].
In this study the components involved in maintaining redox
balance in S. japonicum were investigated through a bioinformatic
approach. Several expressed sequence tags (ESTs) homologous to
the SmTGR gene, but no separate TrxR or GR gene, were found
implying that the TGR gene may also exist in S. japonicum and
plays an important role in redox balance. However, no
information on the S. japonicum TGR (SjTGR) enzymatic system
is currently available. Here we report the gene cloning, protein
expression and purification, as well as enzyme characterization of
SjTGR. The effect of auranofin, a known inhibitor of TGR
[23,24,26,29], against SjTGR was also assessed. The experimental
findings further support TGR as a potential target for develop-
ment of novel drugs against schistosomiasis.
Methods
Ethical statement
The animal work was approved by the Institutional Review
Board (IRB00004221) of Jiangsu Institute of Parasitic Diseases,
Wuxi, China (Permit Number: JIPDAERP20100724). All animals
used in this work were conventionally housed in facilities and were
provided food and water ad libitum. Animal studies including
infection, intraperitoneal injection, orbital venous bleeding of mice
were conducted in accordance with the recommendations in the
Guidelines for the Care and Use of Laboratory Animals of the
Ministry of Science and Technology of People’s Republic of China
([2006]398). Mice were sacrificed by carbon dioxide asphyxiation
in sealed containers according to the Guidelines. All efforts were
made to minimize suffering.
Reagents
5, 9-dithiobis (2-nitrobenzoic acid) (DTNB), glutathione disul-
fide (GSSG) and GSH were purchased from BIO BASIC INC
(Toronto, Canada). The reduced form of NADPH was purchased
from Roche (Basel, Switzerland), and RPMI 1640 was from Gibco
(Invitrogen Corporation, Carlsbad, CA, USA). b-hydroxyethyl
isulfide (HED), insulin and yeast GR was obtained from Sigma (St.
Louis, MO, USA). Auranofin was purchased from ALEXIS
(Lausen, Switzerland). The pGEM-T TA vector was from
Promega (Madison, WI, USA). Finnzymes’ PhusionH high fidelity
polymerase was purchased from New England Biolabs (Ipswich,
MA, USA). Recombinant Trx of S. japonicum was prepared in our
lab. Illustra QuickPrep
TM mRNA purification kit came from GE
Healthcare Life Sciences (Piscataway, NJ, USA). SuperScript
TM
III First Strand Synthesis System was purchased from Invitrogen.
The plasmids pET41a (+) and pSUABC were kindly provided by
Elias S. J. Arne ´r (Department of Medical Biochemistry and
Biophysics, Karolinska Institute, Stockholm, Sweden).
Parasites and animals
S. japonicum cercariae (strain isolated in Jiangsu, China), hatched
from infected Oncomelania hupensis, were provided by the Depart-
ment of Snail Biology, Jiangsu Institute of Parasitic Diseases. Mice
(C57BL/6), weighing 22,24 g, were purchased from the
Shanghai Sub-Center of Experimental Animals, Chinese Academy
of Sciences, and raised in the Department of Experimental
Animals, Jiangsu Institute of Parasitic Diseases.
Preparation of mRNA and first strand cDNA of S.
japonicum adult worms
Each mouse was infected with 50 S. japonicum cercariae by
abdominal skin penetration. All mice were sacrificed on day 45
post-infection, and S. japonicum adult worms were collected through
portal vein perfusion [30]. The mRNA from 0.5 g of S. japonicum
adult worms was prepared by using the Illustra QuickPrep
TM
mRNA purification kit following the manufacturer’s procedures.
The first strand cDNAs were synthesized using mRNA of S.
japonicum adult worms using the SuperScript
TM III First Strand
Synthesis System in accordance with the manual’s instructions.
Cloning of S. japonicum TGR gene
The ESTs of TGR in S. japonicum were BLAST searched with
the S. mansoni TGR DNA sequence. The potential open reading
frame of SjTGR was deduced by comparing all SjTGR ESTs to
the DNA sequence of SmTGR. A pair of gene specific primers
were designed according to the DNA sequence of the deduced
open reading frame of SjTGR, and the primer sequences were as
follows: forward primer: 59-AACATATGCCTCCGATTGATG-
GAACA-39 and reverse primer 1: 59-TC AGCAACCGGT-
TACCGCTGCAGAGCCCCCA-39.
The first strand cDNA of S. japonicum adult worms was used as the
templatetoamplifytheopenreadingframeDNAfragmentencoding
SjTGR using a high fidelity DNA polymerase. The specific DNA
fragment was cloned into the pGEM-T vector after attaching a
deoxyadenine at the 39 terminal by Taq DNA polymerase and
confirmed by sequencing at Invitrogen Corporation.
Construction of the recombinant SjTGR expression
plasmid
The chimeric gene composed of the SjTGR open reading frame
plus a typical bacterial SECIS element was prepared by
overlapping PCR using the following primer pair: forward primer:
59-AACATATGCCTCCGATTGATGGAACA-39 and reverse
TGR as a Novel Drug Target against S. japonicum
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GCAGACCTGCAACCGATTATTAACCTCAGCAACCGGT-
TACCGC-39. The reverse primer 2 included the bacterial SECIS:
59-GGTTAATCGGTTGCAGGTCTGCACCAATCGTTAAC-
CTATGCGCCC-39 [31]. The 59 Nde I site and 39 Sal I site were
introduced into the chimeric gene by PCR for cloning into the
plasmid pET41a containing the corresponding restriction sites.
The insertion in the resulting recombinant expression plasmid
SjTGR-pET41a was confirmed by DNA sequencing at Invitrogen
Corporation.
Expression and purification of recombinant SjTGR
The recombinant SjTGR-pET41a vector and pSUABC vector,
which expresses selA, selB and selC to assist selenocysteine
incorporation into the selenoprotein, were co-transformed into
Escherichia coli BL21 (DE3) competent cells as described by Kuntz
and colleagues [26]. The bacteria grown on Luria–Bertani (LB)
medium plates containing ampicillin (100 mg/mL) and chloram-
phenicol (30 mg/mL) antibiotics were selected as positive clones.
Single colonies containing the SjTGR-pET41a and pSUABC
plasmids were incubated in LB medium containing L-cysteine and
seleniate. When the absorbance value of the bacteria culture at
600 nm reached 2.4, IPTG was added at a final concentration of
0.5 mM. The bacteria were then grown at 24uC for 24 h to induce
SjTGR expression. The expression products were analyzed on a
12% SDS-PAGE gel stained with Commassie Blue.
To confirm that the recombinant SjTGR was a selenoprotein,
the bacteria containing the SjTGR-pET41a and pSUABC
plasmids or those containing only the SjTGR-pET41a plasmid
were inoculated into LB culture medium or induced in LB
medium containing isotope
75Se-cysteine (SeCys). SeCys incorpo-
ration was analyzed on SDS-PAGE gels and autoradiograms.
The recombinant SjTGR was purified by affinity chromatog-
raphy with an adenosine -29,59-diphosphate agarose (ADP-
agarose, Sigma) [32–34]. Briefly, the bacteria cultures were
collected by centrifugation, and the pellets were frozen and
thawed repeatedly until they became transparent. Deoxyribonu-
clease was added to the bacteria lysates to digest the DNA. The
lysate solutions were then centrifuged at 30,0006g for 30 min at
4uC, and the supernatants were passed through 0.45 mm filters.
Samples in all steps above were kept on ice.
ADP-agarose column was equilibrated with buffer containing
50 mM potassium phosphate and 3 mM EDTA, pH 7.5.
Supernatants containing the expressed products above were
diluted ten-fold with the equilibration buffer, applied to the
column, which was rinsed with wash buffer (0.4 M potassium
phosphate, 3 mM EDTA, pH 7.5) until the ultraviolet absorption
of the effluent did not decline further. The recombinant SjTGR
proteins were then eluted with buffer containing 50 mM
potassium phosphate and 0.5 M KCl, pH 7.5, and the fractions
were analyzed by SDS-PAGE. The fractions containing SjTGR
were pooled and applied to another ADP-agarose column, and the
recombinant SjTGR proteins were eluted specifically with an
NADPH linear gradient (0–0.5 mM) in 50 mM phosphate
(pH 7.5). The fractions containing purified SjTGR proteins were
pooled again and stored at 270uC after being dialyzed and
concentrated by ultrafiltration (Amicon Ultra, Millipore, Bedford,
MA, USA).
Production of antiserum against recombinant SjTGR and
immunoblotting
The purified recombinant SjTGR proteins were mixed with
Freund’s complete adjuvant (Sigma) to form water in oil
emulsions. Each mouse was immunized intradermally in the
cervical and back skin with 100 mL of the adjuvanted antigen
(containing 50 mg recombinant SjTGR) and boosted two times
with the same amount of Freund’s incomplete adjuvant antigen at
two week intervals. Blood samples were collected via the orbital
vein on day 7 after the second boost. Antibody titers of sera against
recombinant SjTGR were measured by conventional ELISA.
Purified recombinant SjTGR proteins and the S. japonicum adult
worms homogenates were separated on SDS-PAGE gel and
transferred to nitrocellulose (NC) membrane. After blocking with
5% milk powder solution for 1 h at room temperature, the NC
membrane was incubated with the SjTGR antiserum diluted
1:100 in PBST (PBS with 0.05% Tween-20) for 2 h at room
temperature. The membrane was washed 3 times with PBST, for
10 min each time, and then incubated with HRP-conjugated goat
anti-mice IgG (1:3000 dilution, Bethyl) at room temperature for
2 h. After washing 3 times as above, the colored signals on the
membrane were developed with DAB substrate (6 mg 3,39-
Dianinobenzidine dissolved in 10 ml PBS, 20 mlH 2O2).
SjTGR enzymatic assays
TrxR, GR and Grx activities of recombinant TGR were
analyzed based on the methods described by Kuntz et al. [26] with
a UV-visible spectrophotometer (UV-2550, SHIMADZU) at
25uC. The TrxR activity was determined by the 5, 59-diothiobis
(2-nitrobenzoic acid) (DTNB) reduction assay and the insulin
reduction assay. The DTNB reduction assay solution contained
100 mM NADPH, 3 mM DTNB, 10 mM EDTA in 0.1 M
potassium phosphate (pH 7.4). The increase of absorbance at
412 nm was monitored during the first 2 min. The extinction
coefficient of 13.6 mM
21 cm
21 for TNB was used in the
calculation. One enzyme unit is defined as the NADPH-dependent
production of 2 mmol of 2-nitro-5-thiobenzoic acid per min at
25uC.
Trx reduction assay was determined by monitoring the decrease
of NADPH consumption at 340 nm during the first 2 min. The
assay was carried out in the presence of 1 mg/ml insulin, 10 mM
SjTrx and 100 mM NADPH in 0.1 M potassium phosphate
(pH 7.4) containing 10 mM EDTA. The extinction coefficient of
6.22 mM
21 cm
21 for NADPH was used in the calculation. One
unit of TrxR activity is defined as the oxidation of 1 mmol of
NADPH per min at 25uC.
The GR activity was determined with GSSG. The reaction
mixture contained 100 mM NADPH, 100 mM GSSG in 0.1 M
potassium phosphate (pH 7.4) containing 10 mM EDTA. De-
crease of NADPH consumption at 340 nm during the first 2 min
was monitored. The extinction coefficient of 6.22 mM
21 cm
21 for
NADPH was used in the calculation. One unit GR activity is
defined as the oxidation of 1 mmol of NADPH per min at 25uC.
The Grx activity was determined by monitoring decrease of
NADPH consumption at 340 nm during the first 2 min, and the
assay was performed in the presence of 1 mM GSH, 8 mM HED,
0.6 units of yeast GR, 100 mM NADPH in 0.1 M potassium
phosphate (pH 7.4) containing 10 mM EDTA. The extinction
coeffcient of 6.22 mM
21 cm
21 for NADPH was used in the
calculation. One unit of Grx activity is defined as the oxidation of
1 mmol of NADPH per min at 25uC. All assays were performed in
triplicate.
Kinetic analysis
Based on the method described by Kuntz et al. [26], SjTGR
activities with NADPH, DTNB, SjTrx, GSSG, HED and GSH
were determined in the following buffer: 100 mM NADPH,
10 mM EDTA, 0.1 M potassium phosphate (pH 7.4) and
48 nM SjTGR. In the TrxR activity assay, DTNB concentrations
TGR as a Novel Drug Target against S. japonicum
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100 mM and Trx concentrations from 9 to 34 mM. In the GR
activity, GSSG concentrations were from 10 to 100 mM, and
NADPH was from 5 to 100 mM. In the Grx assay, 2 to 10 mM
HED, 100 to 1500 mM GSH and 10 to 100 mM NADPH were
used. In each reaction, the concentration of one substrate was
changed while keeping the others constant. Kinetic parameters
were obtained by curve fitting of experimental data using
OriginPro 7.0. All assays were performed in triplicate.
Auranofin inhibition of recombinant SjTGR
Inhibition of TrxR, GR and Grx activities of recombinant
SjTGR by different concentrations of auranofin was determined in
the enzyme assays described above. The 50% inhibitory
concentration (IC50) values of auranofin in the various assays
were calculated by curve fitting using the SPSS 13.0 statistical
software.
The inhibitory constants (Ki) of auranofin for TrxR activity and
GR activity of SjTGR were assessed using varying substrate and
inhibitor concentrations as follows: DTNB 100, 150, 200, 300,
500, 700, 1000 mM; GSSG 10, 15, 20, 30, 50, 70, 100 mM;
auranofin 5, 10, 20, 30 nM. The Ki values were calculated using
the following equations [35]:
Kmaxapp~Km 1z I ½  =Ki ðÞ ð 1Þ
1=umaxapp~ 1z I ½  =Ki ðÞ =umax; ð2Þ
Formula (1) is used for calculating Ki of competitive inhibition.
Where Kmaxapp is the apparent Kmax at different inhibitor
concentrations, and I ½ is the inhibitor concentration.
Formula (2) is used for calculating Kiof non-competitive
inhibition. Where umaxappis the apparent umax at different inhibitor
concentrations, and I ½ is the inhibitor concentration.
All assays were performed in triplicate.
Toxicity of auranofin on S. japonicum adult worms
in vitro
Stock solutions of auranofin and praziquantel were prepared by
dissolving 1 mg of the drugs in 0.4 ml dimethyl sulfoxide (DMSO)
and adding 0.6 ml RPMI 1640 medium. S. japonicum worms
obtained from mice (C57BL/6, male, 22,24 g, each infected with
50 cercariae) were washed in RPMI 1640 medium, kept at pH 7.5
with HEPES 20 mM and supplemented with penicillin
(100 UI?mL
21), streptomycin (100 mg?mL
21) and 10% bovine
fetal serum (Gibco) [36]. After washing, two pairs of adult worms
were transferred to each well of a 24-well culture plate containing
2 mL of the same medium. The worms were cultured for 30 to
60 min at 37uC in a humid atmosphere containing 5% CO2, and
then different concentrations of auranofin (1, 5, 10, 20 and 30 mg/ml)
diluted with RPMI 1640 medium were added. Control worms were
treated with equal volumes of RPMI 1640 or DMSO, and worms
treated with 30 mg/mL praziquantel were also observed. The worm
mobility, tegumental alterations and parasite survival were
monitored under an inverted microscope (Leica, Germany) at 1,
6, 24, 48 and 72 h. Parasite death was defined as having no motor
activity during 2 min of continuous observation as well as
morphological and tegumental alterations [37]. Worms treated
with auranofin were homogenized in 0.1 M potassium phosphate
(pH 7.4).Thehomogenateswerecentrifuged at20,0006gfor1 hat
4uC, and the supernatants were assayed for TrxR and GR activities
as described above. All assays were repeated three times.
Auranofin treatments in vivo
A stock solution of auranofin was prepared by dissolving 2 mg
of the drug in 0.4 mL DMSO and adding 0.6 mL of aseptic 0.9%
sodium chloride. The stock solution was diluted to 0.4 mg/mL
with the aseptic 0.9% sodium chloride before use. All mice
(C57BL/6, male, 22,24 g) infected with 30 S. japonicum cercariae
by abdomenal skin exposure were administered 6 mg/kg aur-
anofin injected intraperitoneally twice daily for 5 days beginning
35 days post-infection. Control mice were given the same dose of
carrier on the same timetable. Mice were sacrificed on day 42
post-infection. Worms were counted by portal vein perfusion.
Liver tissues were digested with 5% potassium hydroxyl solution,
and the eggs from the liver tissue were counted. The worm
reduction rate and egg reduction rate were calculated using the
following formulas.
Worm reduction rate (%)~(mean number of adult worms per
mouse in control group - mean number of adult worms per mouse
in experimental group)=mean number of adult worms in control
group.
Egg reduction rate (%)~(mean number of eggs per mouse in
control group - mean number of eggs per mouse in experimental
group)=mean number of eggs per mouse in control group.
Statistical analysis
The numbers of worms and eggs per gram of liver were
expressed as mean values 6 standard errors (SD). Significant
reductions in worm and egg burdens after auranofin treatment
were determined by two-tailed Student t-test using statistical
software SPSS 13.0. Differences between median values were
considered to be significant at the level of 5%.
Results
Cloning and characterization of the SjTGR gene
The cDNA fragment encoding the open reading frame of the
SjTGR protein was amplified from the mRNA of S. japonicum adult
worms using a pair of gene specific primers designed according to
the S. japonicum EST sequence, which showed a high degree of
homology to the SmTGR gene. The cDNA fragment was
composed of 1791 nucleotides encoding 598 amino acids. The
predicted molecular weight of SjTGR was 64.9 kDa with an
isoelectric point of 6.38. The amino acid sequence of SjTGR was
91% identical to SmTGR and 55% similar to human TrxR. Like
SmTGR, the SjTGR protein contained NADPH- and FAD-
binding domains, a dimer interface domain of pyridine nucleotide
disulfide oxidoreductases and the thiol-dislifide redox active center
(-CVNVGC-). A glutaradoxin active site (-CPFC-) was found in its
N-terminus, and its C-terminus contained a conserved tetrapep-
tide sequence GCUG (U: selenocysteine), which is the catalytic
domain of TGR [27].
Expression and selenium incorporation of recombinant
SjTGR
As the synthesis of selenoprotein depends on a highly species-
specific translation mechanism, use of the bacterial-type SECIS
element was necessary in order to express the SjTGR selenopro-
tein in E. coli host cells. The open reading frame DNA sequence of
SjTGR was fused with the SECIS element by PCR to form a
chimeric gene following the procedure described by Arne ´r and
colleagues [31]. The chimeric SjTGR gene was cloned direction-
ally into the expression plasmid pET41a at the restriction enzyme
sites Nde I and Sal I, resulting in the recombinant plasmid SjTGR-
pET41a. Restriction analysis and DNA sequencing confirmed that
TGR as a Novel Drug Target against S. japonicum
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expression plasmid correctly (Fig. 1).
The selenocysteine insertion during selenoprotein translation in
E. coli requires an E. coli-type SECIS element just following the
UGA codon in the selenoprotein mRNA, as well as the products of
the selA, selB, and selC and selD genes [31]. In this study, the
recombinant SjTGR-pET41a plasmid was co-transformed into E.
coli BL21 with the pSUABC vector expressing the selA, selB and
selC genes (encoding selenocysteine synthase, SELB and tRNA
Sec,
respectively) to aid in the production of SjTGR as a putative
selenoprotein. When the cells were induced with 1 mM IPTG for
4 h at 37uC, the SjTGR proteins were expressed in inclusion
bodies, which appeared in the precipitate of the bacterial lysate
obtained by ultrasonication. Little soluble recombinant SjTGR
was found in the supernatant of the bacterial lysate (Fig. 2A).
However, when the growth temperature was reduced to 24uC and
the bacteria were induced with IPTG for 24 h beginning at the
stationary growth stage (OD600 nm of culture reaching 2.4) [38],
soluble SjTGR proteins were produced successfully (Fig. 2B). The
selenocysteine incorporation analysis using
75Se-labeling cysteine
and autoradiograms showed that the products of selA, selB, and
selC could increase the yield of SjTGR, suggesting that it is a
selenoprotein (Fig. 3).
The recombinant SjTGR protein was purified with an
adenosine 29,5 9-diphosphate agarose (Sigma A3515) column,
used for specific affinity purification of NADPH-binding proteins.
The purity of the SjTGR protein sample was more than 95%
(Fig. 4), indicating the NADPH binding capacity of the
recombinant SjTGR.
Western blotting with antiserum against SjTGR
High titer (.1:204,800) antiserum against recombinant SjTGR
was obtained after immunizing mice with the purified recombi-
nant SjTGR. The antiserum could recognize a single protein band
of expected size (MW ,65 kDa) in the supernatant of S. japonicum
adult worms homogenates by Western blotting (Fig. 5). The size of
the recombinant SjTGR band was similar to that of the natural
SjTGR. There were no other protein bands recognized by the
antiserum. These results suggested that the recombinant SjTGR
proteins were immunoreactive, inducing antibodies specific to the
native SjTGR protein, and that no cross-reactive proteins were
present in the S. japonicum adult worm.
Activity and kinetics of recombinant SjTGR
The enzyme activities of purified SjTGR were determined
using a broad range of substrates, and the results showed
that SjTGR possessed the characteristic activities of mam-
malian TrxR, GR and Grx. The specific activities were
8.1160.34 mmol?min
21 mg
21 with DTNB, 3.3360.08 mmol?min
21 mg
21
with Trx, 2.1960.01 mmol?min
21 mg
21 with GSSG, and
12.1060.39 mmol?min
21 mg
21 in a Grx assay coupled to HED.
The TrxR activity (with substrates DTNB and Trx) and the Grx
activity of SjTGR were similar to those of SmTGR, although the
GR activity of SjTGR was lower than that of SmTGR (Table 1).
Figure 1. Analysis of recombinant SjTGR-pET41a by enzyme restriction. (A) Agarose gel (1%) electrophoresis of recombinant SjTGR-pET41a
or pET41a vectors. Lane 1: Purified PCR amplified SjTGR gene fragment of about 1,800 bp. Lane 2: Products of recombinant plasmid SjTGR-pET41a
digested by Nde I/Sal I. The sizes of the pET41a backbone and the SjTGR gene were about 5,000 bp and 1,800 bp, respectively. Lane 3: Products of
plasmid pET 41a digested by Nde I/Sal I. The sizes of the fragments from Nde I/Sal I digestion of pET41a were about 5,000 bp and 900 bp. Lane 4:
Undigested pET 41a plasmid of 5933 bp. Lane 5: Undigested recombinant plasmid SjTGR-pET41a of about 6,800 bp. Note that both undigested
plasmids migrated lower in the gel due to the super-helical structures. MW: DNA molecular weight marker. (B) Schematic diagram of the SjTGR-
pET41a plasmid showing relevant enzyme sites and the SjTGR insert size.
doi:10.1371/journal.pone.0031456.g001
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recombinant SjTGR. (A) Expression products from E. coli BL21
transformed with recombinant SjTGR-pET41a and induced with
1 mmole/L of IPTG at 37uC for 4 h. Lane 1: Supernatant of bacterial
lysate. Lane 2: Precipitate of bacteria lysate resuspended with PBS. The
black arrow indicates the expressed SjTGR protein band. MW: Protein
molecular weight marker. (B) Expression products from transformed or
non-transformed E. coli BL21 induced with 0.5 mmole/L of IPTG at 24uC
for 24 h. Products in precipitates (lane 1) or supernatant (lane 2) of
induced bacteria containing plasmid SjTGR-pET41a show expression of
the recombinant SjTGR (black arrow). Expression products of induced
bacteria containing plasmid pET41a (lane 3) or of induced non-
transformed bacteria (lane 4) are also shown. MW: Protein molecular
weight marker.
doi:10.1371/journal.pone.0031456.g002
Figure 3. Analysis of isotope
75Se-cysteine incorporation. (A)
Profile of expressed protein products on a 12% SDS-PAGE gel. (B)
Autoradiogram profile of expressed products corresponding to the
proteins on SDS-PAGE. Lane 1: Expression products of E.coli BL21
containing plasmid SjTGR-pET41a. Lane 2: Expression products of E.coli
BL21 containing plasmids SjTGR-pET41a and pSUABC. MW: Protein
molecular weight marker. The black dots on the SDS-PAGE gel are the
expression products of E.coli BL21 containing plasmids SjTGR-pET41a
and pSUABC. The expression products containing isotope
75Se-cysteine
(SeCys) were dotted on the SDS-PAGE gel after electrophoresis as a
positive control for autoradiography. The black arrow indicates the
SjTGR selenoprotein developed by autoradiography.
doi:10.1371/journal.pone.0031456.g003
Figure 4. Protein profile of purified recombinant SjTGR. Lane 1:
Purified recombinant SjTGR protein on SDS-PAGE gel stained with
Commassie Blue. MW: Protein molecular weight marker.
doi:10.1371/journal.pone.0031456.g004
Figure 5. Western blotting analysis of S. japonicum worm
homogenate. Adult worm supernatant (lane 1) and purified recom-
binant SjTGR protein (lane 2) detected by mice polyclonal serum
antibodies against recombinant SjTGR. MW: Protein molecular weight
marker.
doi:10.1371/journal.pone.0031456.g005
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0.44 mM (NADPH), 3.2460.40 mM (Trx), 145.0566.31 mM
(DTNB), 49.5566.31 mM (GSSG), 2,7926231 mM( H E D )a n d
3,831654 mM (GSH) (Table 2), which were similar to those of
SmTGR (Table 3). The catalytic efficiencies of SjTGR on TrxR,












Although the Kcat values of recombinant SjTGR with various
substrates were lower than those of SmTGR, the catalytic
efficiencies (Kcat=Km) of both enzymes with the same substrate
were similar (Table 3).
Inhibition of recombinant SjTGR by auranofin
Inhibition of recombinant SjTGR by auranofin was observed
by adding different amounts of the inhibitor into the enzyme assay
system using DTNB, GSSG or HED as substrate. The
experimental results showed that auranofin could inhibit the
TrxR, GR and Grx activities of recombinant SjTGR, and the
inhibitory effects were concentration dependent (Fig. 6A). The
IC50 values were 6.89, 0.47 and 8.12 nM, respectively, for the
DTNB, GSSG and HED substrates with 5 nM recombinant
SjTGR. The inhibitory effect of auranofin on TrxR activity was
competitive, increasing the Km for substrates while the Vmax
remained constant. The inhibitory effect of auranofin on GR
activity was non-competitive, altering the Vmax while the Km for
substrates remained constant. The inhibitory constants (Ki) were
0.762 nm for TrxR activity and 0.034 nm for GR activity
according to apparent Km and Vmax values with various
concentrations of auranofin (Fig. 6B, 6C).
Toxicity of auranofin in cultured S. japonicum adult
worms
The effects of auranofin on cultured worm survival were
observed by culturing the worms in medium containing different
concentrations of auranofin, and the mobility and death rates of
the parasites were monitored. Auranofin at 5 mg/ml (7.40 mM)
resulted in a 53.3% decrease of worm viability after 6 h and 66.7%
after 12 h. By 24 h, 100% mortality was observed. The median
lethal dose (LD50) of auranofin was 2.56 mg/ml (3.78 mM) at 24 h,
with 95% confidence interval 2.09,3.02 mg/ml. Auranofin at
5 mg/ml (7.40 mM) reduced 57.1% of the TrxR activity and 71%
of the GR activity in the S. japonicum adult worms homogenates
compared to that of carrier treated-control worms, and the
inhibitory effects were dose-dependent. No TrxR and GR activity
was observed in the homogenates when the worms were treated
with auranofin at 30 mg/ml (44.22 mM) (Fig. 7A). Additionally, the
inhibitory effects of auranofin on TrxR and GR activities
increased with time (Fig. 7B, 7C).
In vivo activity of auranofin
ICR mice infected with 30 cercariae were treated with 6 mg/kg
auranofin twice daily for 5 days beginning on day 35 post-
infection. The results showed that auranofin could reduce worm
burden by 41.50% and egg burden by 43.18% at the adult worm
stage (Table 4).
Discussion
The antioxidant system plays a critical role in physiological
functions of an organism and protects schistosomes from host
immune attack [16,25]. Instead of having separate TrxR and GR
enzymes, the single TGR protein in platyhelminths carrying these
functions can completely deoxidize both Trx and GSSG [22].
TGR proteins of S. mansoni [22], larval T. crassiceps (cysticerci) [23],
E. granulosus [24] and F. hepatica [25] have all been determined as
potentially important drug targets. S. mansoni adult worms die
when the activity of TGR is inhibited or silenced, as TGR
produces partial or complete protective effects against oxidative
damage in the host [26]. However, little attention has been
focused on targeting the redox system of S. japonicum, a helminth
endemic in Asia, for development of new schistosomicides.
In this study, the TGR gene of S. japonicum was cloned, and the
deduced amino acid sequence of SjTGR revealed that it included
NADPH- and FAD-binding domains, a thiol-disulfide redox active
center (-CVNVGC-) and a Grx active site (-CPFC-). It was found
Table 1. Comparison of recombinant TGR enzyme activities










TrxR NADPH+DTNB 8.1160.34 10.2
NADPH+Trx 3.3360.08 2.2
GR NADPH+GSSG 2.1960.01 7.2
Grx NADPH+HED 12.1060.39 9.9
doi:10.1371/journal.pone.0031456.t001
Table 2. Kinetics of recombinant SjTGR with different
substrates.





NADPH (DTNB) 21.4260.44 31.4560.83 10.92 5.10610
5
Trx 3.2460.40 13.7760.16 4.78 1.48610
6
DTNB 145.0566.31 23.5061.02 8.16 1.19610
5
NADPH (GSSG) 83.24624.27 14.0364.38 4.87 5.85610
4
GSSG 49.5566.31 15.4060.58 5.35 1.08610
5
NADPH (Grx) 10.9762.42 43.0160.18 14.93 1.36610
6
HED 2,7926231 24.9260.67 8.65 3.10610
3
GSH 1,698654 45.4564.28 15.78 9.30610
3
Kinetic constants for recombinant SjTGR (48 nM) were determined in assays
performed at 25uC in 0.1 M potassium phosphate (pH 7.4) with 10 mM EDTA
and 100 mM NADPH. All assays were conducted in triplicate.
doi:10.1371/journal.pone.0031456.t002
Table 3. Comparison of kinetics of recombinant TGR from S.
mansoni and S. japonicum with different substrates.
Substrate S.mansoni [26] S.japonicum













NADPH 13.7 20.1 1.5610
6 21.42 10.92 5.10610
5
Trx 6.37 30 4.7610
6 3.24 4.78 1.48610
6
DTNB 114 16 1.4610
5 145.05 8.16 1.19610
5
GSSG 71.5 21.7 3.0610
5 49.55 5.35 1.08610
5
HED 1,867 17.8 9.6610
3 2,792 8.65 3.10610
3
GSH 248.6 20.1 8.1610
4 1,698 15.78 9.30610
3
doi:10.1371/journal.pone.0031456.t003
TGR as a Novel Drug Target against S. japonicum
PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e31456to be 91% identical to SmTGR and 55% similar to human TrxR.
There were 32 ESTs homologous to SmTGR found by analyzing
ESTs of S. japonicum. One longer EST contained a conservative
SECIS element in the non-translated region following the
Figure 6. Inhibition of auranofin on enzymatic activities of
recombinant SjTGR. (A) Percentages of TrxR, GR and Grx activities
inhibited by different doses of auranofin with DTNB, GSSG or HED as
substrate. (B) Inhibition constant (Ki) values of auranofin on
recombinant SjTGR in the TrxR assay. The straight lines were fitted on
the basis of the reciprocal of concentration of substrate and initial
velocity. The concentrations of auranofin were 0 nM, 5 nM, 10 nM and
15 nM, and DTNB ranged from 60 to 1,000 mM. (C) Inhibition constant
(Ki) values of auranofin on SjTGR in the GR activity assay. The straight
lines were fitted on the basis of the reciprocal of concentration of
substrate and initial velocity. The concentrations of auranofin were
0 nM, 5 nM, 10 nM and 20 nM, and GSSG ranged from 10 to 100 mM.
doi:10.1371/journal.pone.0031456.g006
Figure 7. Inhibition of S. japonicum adult worms by auranofin in
vitro. (A) Effects of auranofin (AUF 1, 5, 10, 20, 30 mg/ml) on TrxR and
GR activities of adult worms after 3 h of treatment. Worms were mock
treated in the control groups (RPMI 1640 and 1.2% DMSO). Worms were
treated with 30 mg/ml of praziquantel in the PZQ 30 mg/ml group. (B)
Inhibition of auranofin on TrxR activity of adult worms over time.
Worms were treated with 5 and 10 mg/ml of auranofin, and the TrxR
activities of worm homogenates were tested after 0, 1, 3 and 6 h. (C)
Inhibition of auranofin on GR activity of adult worms over time. Worms
were treated with 5 and 10 mg/ml of auranofin, and the GR activities of
worm homogenates were tested after 0, 1, 3 and 6 h.
doi:10.1371/journal.pone.0031456.g007
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SECIS element mediates the selenocysteine insertion at the
penultimate amino acid of TGR functioning in concert with an
adjacent cysteine as an essential part of this redox center [39],
implying that SjTGR is also a selenoprotein enzyme like the
mammalian TrxR isoforms. As selenoprotein synthesis is a highly
species-specific process, we fused the SjTGR cDNA with the
SECIS sequence of E. coli in constructing the recombinant
SjTGR-pET41a plasmid in order to express the SjTGR
selenoprotein in E.coli host cells [31]. Co-transformation of this
plasmid into E.coli BL21 along with the pSUABC plasmid
expressing selA, selB, and selC that provided proteins to aid in
the production of selenoproteins successfully yielded a soluble
65 kDa SjTGR protein upon IPTG induction. The selenocysteine
incorporation analysis using
75Se-labeling cysteine and autoradio-
grams showed that the products of selA, selB, and selC could
increase the yield of SjTGR proteins. These results also confirmed
that SjTGR is a selenoprotein.
Using the same methods previously published for production of
recombinant SmTGR and conditions for enzyme kinetics analysis
[26], the experimental data in the present study showed
that SjTGR is a multifunctional enzyme with TrxR, GR and
Grx activities. The GR activity of SjTGR was lower than that in
SmTGR(2.1960.01 mmol?min
21 mg
21 vs. 7.2 mmol?min
21 mg
21).
However, the lower activity was compensated by the lower Km








the GR catalytic efficiencies of SjTGR and SmTGR were
comparable.
The Kcat=Km with Trx (1.48610
6 M
21?s
21) was about 10








support the hypothesis that the catalytic efficiency of TGR with
Trx was higher than that with GSSG and HED. The Trx/GSSG
ratios of 3.3 and 15.7 in T. crassiceps [23] and S. mansoni [26] have
also been reported. In all cases, TGR showed a preference toward
Trx as substrate.
Compared to the TrxR Km (21.4260.44 mM) and GR Km
(83.24624.27 mM) of SjTGR, the Grx Km (10.9762.42 mM) with
NADPH was the lowest, which suggests that NADPH, combined
with SjTGR, tends to deliver electrons to the Grx activity domain
first and then to Trx. In S. mansoni, the electrons flow within the
TGR domain from NADPH to the C terminus, then from the C
terminus to either Trx or the Grx domain [40]. Electrons are
selectively delivered to the acceptor by the C-terminal arm
shuttling between SmTrx and the Grx domain [40]. Further study
on the direction of electron transfer of SjTGR will be surveyed in
our future work.







21) [42], it is obvious that the catalytic
efficiencies of TrxR from helminths fall into the same range, but
their GR catalytic efficiencies were all lower than that of human
TrxR (Table 3). One possible reason for this phenomenon is that
schistosomes may use the reduced GSH derived from host
erythrocytes they ingest to maintain their redox balance,
decreasing the requirement of GSSG reduction accordingly. Our
results also provide evidence that schistosome TGR is not an
efficient GR [40].
High titer (.1:204,800) antiserum was obtained after immu-
nizing mice with the purified recombinant SjTGR. In Western
blot analysis, the polyclonal antibodies in this antiserum could
recognize a ,65 kDa protein band corresponding to the expected
size of SjTGR in the supernatant of S. japonicum adult worms
homogenates, indicating that the recombinant SjTGR was
immunogenic and induced antibodies reactive to the natural
protein. Furthermore, this antiserum did not react with other
bands in the worm supernatant. Since the amino acid sequence of
TGR is highly homologous to the 56 kDa TrxR and 52 kDa GR
of eukaryotic cells, if individual TrxR or GR proteins exist in the S.
japonicum adult worm, the corresponding cross-reactive protein
bands would have been detected. These results indicate that the S.
japonicum adult worm does not express separate TrxR or GR
molecules, the functions of which are entirely replaced by TGR.
This point was also confirmed by bioinformatic analysis which
found no TrxR or GR EST sequences in the S. japonicum EST
database (data not published). These data reported here suggest
that SjTGR plays a key role in the maintenance of redox balance
in S. japonicum.
In the study, the gold compound auranofin, a known inhibitor
of TGR, was found to inhibit the activity of the recombinant
SjTGR. The IC50 values of auranofin against TrxR, GR and Grx
activities were in the nanomolar range (6.89, 0.47, 8.12 nM) with
5 nM recombinant SjTGR. Of note, the IC50 value of auranonfin
on GR in S. mansoni worms was almost 9 times higher than that in
S. japonicum, while the IC50 values against TrxR and Grx were
nearly the same. Interestingly, the inhibitory mechanisms of
auranofin against TrxR and GR were distinct. Auranofin-
mediated inhibition of TrxR activity was competitive, while that
of GR activity was non-competitive. This may be due to
differences in the structures of auranofin, DTNB and GSSG.
Auranofin has a benzene ring structure [43], which is similar to
DTNB with two benzene rings connected by a disulfide bond [44],
but different from the carbon chain of GSSG [45]. Auranofin and
DTNB may combine with the active center of TGR competitively,
but auranofin may combine outside of the active center of GR to
influence the GR activity of SjTGR in a non-competitive manner.
The Ki value of auranofin on TrxR and GR was very low
(0.762 nM and 0.034 nM), indicating that just a small amount of
auranofin could completely inhibit SjTGR activity, similar to the
findings in larval T. crassiceps [23], E. granulosus [24] and S. mansoni
[43].
Auranofin was confirmed to be toxic to S. japonicum adult worms
in vitro, and the dose of 5 mg/ml (7.40 mM) resulted in 100%
mortality after 24 h. The calculated LD50 of auranofin against S.
japonicum adult worms in vitro was 2.56 mg/ml (3.78 mM) at 24 h.
These results are in agreement with those reported from S. mansoni










Control 11 23.2565.91 96639.23630692.60
Auranofin 10 13.6066.47 41.50* 54907.33635530.09 43.18*
*Auranofin treatment versus control, P,0.01 by t-test.
doi:10.1371/journal.pone.0031456.t004
TGR as a Novel Drug Target against S. japonicum
PLoS ONE | www.plosone.org 9 February 2012 | Volume 7 | Issue 2 | e31456adult worms [26], E. granulosus larval worms [46] and T. crassiceps
metacestode [47]. In vivo, 6 mg/kg auranfin could partially cure S.
japonicum-infected mice, with a 41.50% reduction in worm burden
and a 43.18% reduction in egg burden. We obtained similar
results to those previously observed in S. mansoni treated with
auranofin [26].
As SjTGR is highly similar to SmTGR in terms of amino acid
sequence and activities, it may be a potentially important drug
target as well. However, there are some differences between
SmTGR and SjTGR. The Grx activity motif of SjTGR is
composed of CPFC compared to CPYC in SmTGR [27]. The
differences in amino acid sequence in the TrxR domain of TGR
between S. mansoni and S. japonicum are more marked [39]. The
potential differences in the molecular structures between SjTGR
and SmTGR may result in different inhibitory effects of drugs
targeting these proteins. Of course, further protein homology
modeling and crystallographic structural studies will be required to
better understand TGR as a drug target. Such studies can benefit
in the development of new chemotherapeutic drugs targeting
multiple schistosome species. Meanwhile, the unique aspects of the
SjTGR structure may help to improve potency of these new drugs
against S. japonicum.
In conclusion, our study confirms that a multifunctional enzyme
SjTGR selenoprotein, instead of separate TrxR and GR enzymes,
exists in S. japonicum, which is an extension of findings on TGR in
other platyhelminths. SjTGR plays an essential role in maintaining
the redox balance in S. japonicum, which further confirms TGR as a
potential target for the development of new drugs against
schistosomiasis.
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